Cart
sales@molnova.com
Hydrocortisone 21-hemisuccinate
CAS No. 2203-97-6
Hydrocortisone 21-hemisuccinate( Hydrocortisone hemisuccinate anhydrous )
Catalog No. M18250 CAS No. 2203-97-6
Hydrocortisone 21-hemisuccinate is a corticosteroid used as an analytical and chromatography reagent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 43 | In Stock |
|
| 10MG | 29 | In Stock |
|
| 25MG | 41 | In Stock |
|
| 50MG | 57 | In Stock |
|
| 100MG | 73 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 179 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHydrocortisone 21-hemisuccinate
-
NoteResearch use only, not for human use.
-
Brief DescriptionHydrocortisone 21-hemisuccinate is a corticosteroid used as an analytical and chromatography reagent.
-
DescriptionHydrocortisone hemisuccinate anhydrous is an anti-inflammatory agent.(In Vitro):Hydrocortisone hemisuccinate inhibits IL-6 and IL-3 bioactivity, with IC50s of 6.7 and 21.4 μM, respectively, and shows no cytotoxic effects on IL-6-independent MH60 cells.Hydrocortisone hemisuccinate (0.12-60 μM; 72 h) inhibits phytohemagglutinin (PHA) response in peripheral lymphocytes (PBL) and T-lymphocytes cultures.(In Vivo):Hydrocortisone hemisuccinate (30 mg/kg; p.o. twice daily for 5 d) reduces the weight loss and increases the food intake in mice.
-
In VitroHydrocortisone hemisuccinate inhibits IL-6 and IL-3 bioactivity, with IC50s of 6.7 and 21.4 μM, respectively, and shows no cytotoxic effects on IL-6-independent MH60 cells.Hydrocortisone hemisuccinate (0.12-60 μM; 72 h) inhibits phytohemagglutinin (PHA) response in peripheral lymphocytes (PBL) and T-lymphocytes cultures.
-
In VivoHydrocortisone hemisuccinate (30 mg/kg; p.o. twice daily for 5 d) reduces the weight loss and increases the food intake in mice. Animal Model:Male Sprague-Dawley rats (200-220 g, 10-11 weeks) are induced colitis Dosage:30 mg/kg Administration:P.o. twice daily for 5 days Result:Significantly decreased the disease activity index (DAI) scores and myeloperoxidase (MPO) activity compared to the 2, 4, 6-trinitrobenzenesulfonic acid (TNBS) group.Increased the body weight.
-
SynonymsHydrocortisone hemisuccinate anhydrous
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2203-97-6
-
Formula Weight462.53
-
Molecular FormulaC25H34O8
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (540.51 mM)
-
SMILES[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
-
Chemical Name4-(2-((8S,9R,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)-4-oxobutanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
TAT 14
TAT 14, a 14-mer peptide, is an Nrf2 activator with anti-inflammatory properties. TAT-14 increases Nrf2 protein levels due to targeting the Nrf2 binding site on Keap1, but has no effect on Nrf2 mRNA expression.
-
NNMTi
NNMTi? is a substrate site-targeting, selective nicotinamide N-methyltransferase (NNMT) inhibitor (IC50 = 1.2 μM;?50 μM SAM, 100 μM NCA) that reduces 3T3-L1 lipogenesis (EC50 = 30μM) and adipocytes 1-methylnicotinamide level (EC50 = 2.3 μM) without affecting related methyltransferases & enzymes in the NAD+ salvage pathwayNNMTi treatment will rescue age-related deficits in muSC activity to promote superior regeneration post-injury in aging muscle.
-
Biotin-β-Endomorphin...
Biotin-β-Endomorphin, human
